Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Praxis Precision Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:08 pm Purchase | 2024-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Venrock Healthcare Capital Partners III, L.P. | 1,190,340 6.100% | 283,854 (+31.31%) | Filing |
| 2024-11-14 5:50 pm Purchase | 2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX | Venrock Healthcare Capital Partners III, L.P. | 906,486 5.000% | 82,860 (+10.06%) | Filing |
| 2024-02-14 8:45 pm Purchase | 2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Venrock Healthcare Capital Partners III, L.P. | 823,626 8.900% | 823,626 (New Position) | Filing |